Who owns Chugai Pharmaceutic-unsp?
- Ticker: CHGCY
- CUSIP Number: 171269103
Tip: Access positions for across all investors
Analyze quarterly positions in Chugai Pharmaceutic-unsp with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Chugai Pharmaceutic-unsp stock
Who bought or sold Chugai Pharmaceutic-unsp this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sterling Capital Management | 47k | $1.0M | -36% | Sep 2025 |
|
| Confluence Investment Management | 43k | $959k | 10% | Sep 2025 |
|
| Rhumbline Advisers | 28k | $612k | -1% | Sep 2025 |
|
| GAMMA Investing | 11k | $236k | -3% | Sep 2025 |
|
| Pnc Financial Services | 11k | $234k | -15% | Sep 2025 |
|
| Salomon & Ludwin | 481.00 | $12k | 2572% | Sep 2025 |
|
| Hantz Financial Services | 297.00 | $7.0k | -25% | Sep 2025 |
|
| Accent Capital Management | 200.00 | $4.4k | 0% | Sep 2025 |
|
Who sold out of Chugai Pharmaceutic-unsp?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Riverbrige Partners | Jun 2025 | 11k | $281k |
| Skopos Labs | Jun 2025 | 1.5k | $38k |
| Thurston, Springer, Miller, Herd & Titak | Jun 2025 | 256.00 | $6.7k |